Geneos Wealth Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3
| Closed | – | – | 2534 |
|
|
2022
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2786 |
|
|
2021
Q3 | – | Sell |
-3
| Closed | -$1K | – | 2904 |
|
|
2021
Q2 | $1K | Sell |
3
-13
| -81% | -$4.33K | ﹤0.01% | 2802 |
|
|
2021
Q1 | $8K | Hold |
16
| – | – | ﹤0.01% | 2500 |
|
|
2020
Q4 | $9K | Hold |
16
| – | – | ﹤0.01% | 2273 |
|
|
2020
Q3 | $6K | Hold |
16
| – | – | ﹤0.01% | 2138 |
|
|
2020
Q2 | $8K | Sell |
16
-1
| -6% | -$500 | ﹤0.01% | 2007 |
|
|
2020
Q1 | $6K | Hold |
17
| – | – | ﹤0.01% | 1998 |
|
|
2019
Q4 | $12K | Hold |
17
| – | – | ﹤0.01% | 1906 |
|
|
2019
Q3 | $10K | Hold |
17
| – | – | ﹤0.01% | 1903 |
|
|
2019
Q2 | $14K | Hold |
17
| – | – | ﹤0.01% | 1790 |
|
|
2019
Q1 | $9K | Hold |
17
| – | – | ﹤0.01% | 1878 |
|
|
2018
Q4 | $4K | Hold |
17
| – | – | ﹤0.01% | 2072 |
|
|
2018
Q3 | $7K | Hold |
17
| – | – | ﹤0.01% | 1990 |
|
|
2018
Q2 | $7K | Hold |
17
| – | – | ﹤0.01% | 1850 |
|
|
2018
Q1 | $9K | Buy |
17
+1
| +6% | +$529 | ﹤0.01% | 1692 |
|
|
2017
Q4 | $10K | Hold |
16
| – | – | ﹤0.01% | 1643 |
|
|
2017
Q3 | $15K | Hold |
16
| – | – | ﹤0.01% | 1439 |
|
|
2017
Q2 | $15K | Buy |
16
+3
| +23% | +$2.81K | ﹤0.01% | 1388 |
|
|
2017
Q1 | $12K | Hold |
13
| – | – | ﹤0.01% | 1431 |
|
|
2016
Q4 | $10K | Hold |
13
| – | – | ﹤0.01% | 1435 |
|
|
2016
Q3 | $11K | Hold |
13
| – | – | ﹤0.01% | 1344 |
|
|
2016
Q2 | $11K | Sell |
13
-5
| -28% | -$4.23K | ﹤0.01% | 1303 |
|
|
2016
Q1 | $20K | Buy |
+18
| New | +$20K | ﹤0.01% | 1093 |
|